Ordinary Shares International Reporting
Verified Company Profile 5/01/2017
Contact Info
  • c.o DiaMedica USA Inc.
  • 2 Carlson Pkwy, Ste 165
  • Minneapolis, MN 55447

Business Description

Financial Reporting/Disclosure
Reporting Status International Reporting: TSX Venture Exchange
Audited Financials Audited
Latest Report Jun 30, 2017 Interim Financial Report
CIK 0001401040
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: Manitoba, Canada
Year of Inc. 2000
Employees Not Available
Company Officers/Contacts
Rick John Pauls President, CEO
Paul Papi VP, Bus. Dev. & Corp. Rel.
David Gurvey VP, Fin.
Todd Verdoorn CSO
Donna Husemoller Corporate Controller
Company Directors
Richard Dal Pilnik Chairman
Michael Giuffre
James Parsons
Zhenyu "Jerry" Xiao
Company Notes
  • Formerly=Diamedica, Inc. until 12-2016
Service Providers
Accounting/Auditing Firm
333 Bay Street Suite 4600
Bay Adelaide Centre
Toronto, ONT, M5H 2S5

Legal Counsel
Pushor Mitchell LLP
301-1665 Ellis Street
Kelowna, BC, V1Y 2B3

Investor Relations Firm
Not Available
DMCAF Security Details
Share Structure
Market Value1 $26,922,147 a/o Sep 20, 2017
Authorized Shares Unlimited a/o Jun 29, 2016
Outstanding Shares 121,107,275 a/o Apr 30, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float Not Available
Par Value No Par Value
Transfer Agent(s)
Shareholders of Record Not Available
Non US Stock Exchange Listing
DMA - TSX Venture Exchange - Qualified
Short Selling Data
Short Interest 600 (0%)
Aug 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security